-
POPULATION EFFECTS OF PNEUMOCOCCAL CONJUGATE VACCINES ON INVASIVE PNEUMOCOCCAL DISEASE IN CANADA — A TARGETED LITERATURE REVIEW
Feb 25, 2026, 14:40 PM -
TRENDS AND ANNUALIZED CHANGES IN HUMAN PAPILLOMAVIRUS (HPV) VACCINATION AMONG ADOLESCENTS IN THE UNITED STATES, 2013-2023
Feb 25, 2026, 14:40 PM -
RECEIPT OF SARS-COV2 MRNA VACCINE PRIOR TO IMMUNE CHECKPOINT INHIBITOR THERAPY ASSOCIATED WITH SIGNIFICANTLY IMPROVED OVERALL SURVIVAL ACROSS MULTIPLE METASTATIC CANCERS: RESULTS FROM A REAL-WORLD EVIDENCE STUDY
Feb 25, 2026, 14:40 PM -
COST-UTILITY MODEL OF MATERNAL RSV VACCINATION FROM THE PERSPECTIVE OF THE BRAZILIAN PUBLIC HEALTH SYSTEM
Feb 25, 2026, 14:40 PM -
UNMET MEDICAL CARE NEEDS AMONG PATIENTS WITH DEMENTIA AND THEIR FAMILY MEMBERS: A HOUSEHOLD-LEVEL ANALYSIS OF MEPS
Feb 25, 2026, 14:40 PM -
FORECASTING CLINICAL OUTCOMES FROM LIMITED REAL-WORLD DATA: A COMPARATIVE SIMULATION STUDY
Feb 25, 2026, 14:40 PM -
COMPARINGHEALTHCARE UTILIZATION, EXPENDITURES, AND QUALITY OF LIFE AMONG ADULTSWITHANDWITHOUTMOOD DISORDERS
Feb 25, 2026, 14:40 PM -
THE COST-EFFECTIVENESS AND GLOBAL REIMBURSEMENT LANDSCAPE FOR DENOSUMAB IN ONCOLOGY
Feb 25, 2026, 14:40 PM -
SOCIO-DEMOGRAPHIC FACTORS AND ADHERENCE TO COLORECTAL CANCER SCREENING GUIDELINES IN THE UNITED STATES: EVIDENCE FROM BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM DATA
Feb 25, 2026, 14:40 PM -
EVALUATING THE COST BENEFIT OF SEAMLESS MD MOBILE HEALTH PLATFORM TO IMPROVING SURGICAL OUTCOMES: PRELIMINARY FINDINGS ON SOCIETAL COSTS FOLLOWING KNEE REPLACEMENT SURGERY AT NIAGARA HEALTH
Feb 25, 2026, 14:40 PM -
TARGETED THERAPY, IMMUNOTHERAPY, AND MOLECULAR TESTING IN ADVANCED SOLID TUMORS: A 2021-2025 MEDICARE ANALYSIS
Feb 25, 2026, 14:40 PM -
GLOBAL EPIDEMIOLOGICAL ASSESSMENT OF THE DISEASE BURDEN OF OSTEOARTHRITIS IN 2023
Feb 25, 2026, 14:40 PM -
MULTIMODAL ASSESSMENT OF ICD-CODED SARCOPENIA DIAGNOSES IN THE REAL-WORLD SETTING
Feb 25, 2026, 14:40 PM -
COST-EFFECTIVENESS OF POLYGENIC RISK-GUIDED BREAST CANCER SCREENING WITH AND WITHOUT HBOC TESTING: A DISCRETE-EVENT SIMULATION WITH PROBABILISTIC SENSITIVITY ANALYSIS
Feb 25, 2026, 14:40 PM -
ANALYSIS OF FDA REVIEW COMMENTS ON PATIENT-REPORTED OUTCOMES IN NEW DRUG APPLICATIONS(2021-2025)
Feb 25, 2026, 14:40 PM -
EVALUATING THE PERFORMANCE AND OPTIMAL USE STRATEGY OF AN ARTIFICIAL INTELLIGENCE (AI)-ASSISTED TOOL FOR ONCOLOGY LITERATURE REVIEW
Feb 25, 2026, 14:40 PM -
IMPACT OF THE COVID-19 PANDEMIC ON HEALTHCARE EXPENDITURE AND RESOURCE USE IN PEOPLE LIVING WITH HIV IN THE UNITED STATES: A DIFFERENCE-IN-DIFFERENCE ANALYSIS
Feb 25, 2026, 14:40 PM -
PATIENT EXPERIENCE AND NET PROMOTER SCORE IN A STRUCTURED DERMATOLOGICAL IMMUNOBIOLOGIC CARE MODEL: REAL-WORLD EVIDENCE TO SUPPORT VALUE-BASED HEALTHCARE
Feb 25, 2026, 14:40 PM -
HEALTHCARE UTILIZATION, EXPENDITURES, AND HEALTH-RELATED QUALITY OF LIFE AMONG U.S. ADULTS WITH RHEUMATOID ARTHRITIS AND COMORBID HYPERTENSION: MEDICAL EXPENDITURE PANEL SURVEY, 2020-2023
Feb 25, 2026, 14:40 PM -
REAL-WORLD SAFETY TRENDS OF GLP-1 RECEPTOR AGONISTS IN THE UNITED STATES: ANALYSIS OF FAERS REPORTS (2015-2025)
Feb 25, 2026, 14:40 PM
